Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Sidoni

Showing results (91-100 of 152) with videos related to

Pageof 16
Sort By:
Medical Oncology (Northwood, London, England)|April 19, 2018
Precision medicine against ALK-positive non-small cell lung cancer: beyond crizotinibBiagio Ricciuti, Andrea De Giglio, Carmen Mecca, et al.
Lung Cancer (Amsterdam, Netherlands)|May 12, 2018
Long-term survival with erlotinib in advanced lung adenocarcinoma harboring synchronous EGFR G719S and KRAS G12C mutationsBiagio Ricciuti, Sara Baglivo, Vienna Ludovini, et al.
Pediatric Blood & Cancer|July 17, 2015
Molecular Cytogenetics Detect an Unbalanced t(2;13)(q36;q14) and PAX3-FOXO1 Fusion in Rhabdomyosarcoma With Mixed Embryonal/Alveolar FeaturesRoberta La Starza, Valeria Nofrini, Tiziana Pierini, et al.
Oncotargets and Therapy|July 23, 2014
Discordance rate of HER2 status in primary breast carcinomas versus synchronous axillary lymph node metastases: a multicenter retrospective investigationAntonio Ieni, Valeria Barresi, Rosario Caltabiano, et al.
Lung Cancer (Amsterdam, Netherlands)|December 4, 2003
The clinical relevance of Bcl-2, Rb and p53 expression in advanced non-small cell lung cancerVanesa Gregorc, Samir Darwish, Vienna Ludovini, et al.
Lung Cancer (Amsterdam, Netherlands)|December 25, 2002
Relevance of p53, bcl-2 and Rb expression on resistance to cisplatin-based chemotherapy in advanced non-small cell lung cancerVanesa Gregorc, Vienna Ludovini, Lorenza Pistola, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 9, 2024
The development of artificial intelligence in the histological diagnosis of Inflammatory Bowel Disease (IBD-AI)Cesare Furlanello, Nicole Bussola, Nicolò Merzi, et al.
International Journal of Molecular Sciences|December 23, 2023
Sphingomyelin Metabolism Modifies Luminal A Breast Cancer Cell Line under a High Dose of Vitamin CMichela Codini, Federico Fiorani, Martina Mandarano, et al.
Mediators of Inflammation|May 20, 2016
e-Cadherin in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Induced Parkinson DiseaseSamuela Cataldi, Michela Codini, Stéphane Hunot, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 3, 2018
OsimertinibUmberto Malapelle, Biagio Ricciuti, Sara Baglivo, et al.
Pageof 16

Showing results (91-100 of 152) with videos related to

Sort By:
Pageof 16
Medical Oncology (Northwood, London, England)|April 19, 2018
Precision medicine against ALK-positive non-small cell lung cancer: beyond crizotinibBiagio Ricciuti, Andrea De Giglio, Carmen Mecca, et al.
Lung Cancer (Amsterdam, Netherlands)|May 12, 2018
Long-term survival with erlotinib in advanced lung adenocarcinoma harboring synchronous EGFR G719S and KRAS G12C mutationsBiagio Ricciuti, Sara Baglivo, Vienna Ludovini, et al.
Pediatric Blood & Cancer|July 17, 2015
Molecular Cytogenetics Detect an Unbalanced t(2;13)(q36;q14) and PAX3-FOXO1 Fusion in Rhabdomyosarcoma With Mixed Embryonal/Alveolar FeaturesRoberta La Starza, Valeria Nofrini, Tiziana Pierini, et al.
Oncotargets and Therapy|July 23, 2014
Discordance rate of HER2 status in primary breast carcinomas versus synchronous axillary lymph node metastases: a multicenter retrospective investigationAntonio Ieni, Valeria Barresi, Rosario Caltabiano, et al.
Lung Cancer (Amsterdam, Netherlands)|December 4, 2003
The clinical relevance of Bcl-2, Rb and p53 expression in advanced non-small cell lung cancerVanesa Gregorc, Samir Darwish, Vienna Ludovini, et al.
Lung Cancer (Amsterdam, Netherlands)|December 25, 2002
Relevance of p53, bcl-2 and Rb expression on resistance to cisplatin-based chemotherapy in advanced non-small cell lung cancerVanesa Gregorc, Vienna Ludovini, Lorenza Pistola, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 9, 2024
The development of artificial intelligence in the histological diagnosis of Inflammatory Bowel Disease (IBD-AI)Cesare Furlanello, Nicole Bussola, Nicolò Merzi, et al.
International Journal of Molecular Sciences|December 23, 2023
Sphingomyelin Metabolism Modifies Luminal A Breast Cancer Cell Line under a High Dose of Vitamin CMichela Codini, Federico Fiorani, Martina Mandarano, et al.
Mediators of Inflammation|May 20, 2016
e-Cadherin in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Induced Parkinson DiseaseSamuela Cataldi, Michela Codini, Stéphane Hunot, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 3, 2018
OsimertinibUmberto Malapelle, Biagio Ricciuti, Sara Baglivo, et al.
Pageof 16